Oral human immunoglobulin for children with autism and gastrointestinal dysfunction: A prospective, open-label study

Journal of Autism and Developmental Disorders

Volumn 36, Issue 8, 2006, Pages 1053-1064

  Schneider, Cindy K ^a,b   Melmed, Raun D ^a   Barstow, Leon E ^c   Enriquez, F Javier ^c,e   Ranger Moore, James ^f   Ostrem, James A ^c,d  

^a Southwest Autism Research and Resource Center   (United States)

^b Center for Autism Research and Education   (United States)

^c Protein Technologies Inc   (United States)

^d ImaRx Therapeutics Inc   (United States)

^e UCB Clinical Development   (United States)

^f UNIVERSITY OF ARIZONA   (United States)

Author keywords

Autism; Autistic Disorder; Gastrointestinal dysfunction; Immunoglobulin; Mucosal immunity

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; AUTISM; BEHAVIOR; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE SEVERITY; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNE SYSTEM; MALE; MUCOSAL IMMUNITY; PARENT; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; GASTROINTESTINAL DISEASES; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 33845884296     PISSN: 01623257     EISSN: 15733432     Source Type: Journal    
DOI: 10.1007/s10803-006-0141-y     Document Type: Article

References (46)

1. Anthony, A., Bjarnason, I., Sigthorsson, G., Montgomery, S. M., Murch, S. H., & Thompson, M., et al. (2000). Faecal calprotectin levels correlate with acute inflammation in autistic enterocolitis. Gut, 46(Suppl II), A3.
2. Arnold, L. E., Aman, M. G., Martin, A., Collier-Crespin, A., Vitiello, B., & Tierney, E., et al. (2000). Assessment in multisite randomized clinical trials of patients with autistic disorder: The Autism RUPP Network. Research Units on Pediatric Psychopharmacology. Journal of Autism and Developmental Disorders, 30(2), 99-111.
3. Ashwood, P., Anthony, A., Pellicer, A. A., Torrente, F., Walker-Smith, J. A., & Wakefield, A. J. (2003). Intestinal lymphocyte populations in children with regressive autism: Evidence for extensive mucosal immunopathology. Journal of Clinical Immunology, 23(6), 504-517.
4. Barnes, G. L., Doyle, L. W., Hewson, P. H., Knoches, A. M., McLellan, J. A., & Kitchen, W. H., et al. (1982). A randomised trial of oral gammaglobulin in low-birth-weight infants infected with rotavirus. Lancet, 1(8286), 1371-1373.
5. Casswall, T. H., Hammarstrom, L., Veress, B., Nord, C. E., Bogstedt, A., & Brockstedt U., et al. (1996). Oral IgA-IgG treatment of chronic non-specific diarrhoea in infants and children. Acta Paediatrica, 85(9), 1126-1128.
6. Chez, M. G., Buchanan, C. P., Bagan, B. T., Hammer, M. S., McCarthy, K. S., & Ovrutskaya, I., et al. (2000). Secretin and autism: A two-part clinical investigation. Journal of Autism and Developmental Disorders, 30(2), 87-94.
7. Comi, A. M., Zimmerman, A. W., Frye, V. H., Law, P. A., & Peeden, J. N. (1999). Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. Journal of Child Neurology, 14(6), 388-394.
8. Connolly, A. M., Chez, M. G., Pestronk, A., Arnold, S. T., Mehta, S., Deuel, R. K. (1999). Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. Journal of Pediatrics, 134(5), 607-613.
9. Dalakas, M. C. (1997). Intravenous immune globulin therapy for neurologic diseases. Annals of Internal Medicine, 126(9), 721-730.
10. Daniels, W. W., Warren, R. P., Odell, J. D., Maciulis, A., Burger, R. A., & Warren, W. L., et al. (1995). Increased frequency of the extended or ancestral haplotype B44-SC30-DR4 in autism. Neuropsychobiology, 32(3), 120-123.
11. Eibl, M. M., Wolf, H. M., Furnkranz, H., & Rosenkranz, A. (1988). Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding. New England Journal of Medicine, 319(1), 1-7.
12. Furlano, R. I., Anthony, A., Day, R., Brown, A., McGarvey, L., & Thomson, M. A., et al. (2001). Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. Journal of Pediatrics, 138(3), 366-372.
13. Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn's-disease activity. Lancet, 1(8167), 514.
14. Horvath, K., Papadimitriou, J. C., Rabsztyn, A., Drachenberg, C., & Tildon, J. T. (1999). Gastrointestinal abnormalities in children with autistic disorder. Journal of Pediatrics, 135(5), 559-563.
15. Horvath, K., & Perman, J. A. (2002). Autism and gastrointestinal symptoms. Current Gastroenterology Reports, 4(3), 251-258.
16. Hyams, J. S., Mandel, F., Ferry, G. D., Gryboski, J. D., Kibort, P. M., Kirschner B. S., et al. (1992). Relationship of common laboratory parameters to the activity of Crohn's disease in children. Journal of Pediatric Gastroenterology and Nutrition, 14(2), 216-222.
17. Jyonouchi, H., Sun, S., & Le, H. (2001). Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. Journal of Neuroimmunology, 120(1-2), 170-179.
18. Kanfer, E. J., Abrahamson, G., Taylor, J., Coleman, J. C., & Samson, D. M. (1994). Severe rotavirus-associated diarrhoea following bone marrow transplantation: treatment with oral immunoglobulin. Bone Marrow Transplantation, 14(4), 651-652.
19. Kazatchkine, M. D., & Kaveri, S. V. (2001). Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. New England Journal of Medicine, 345(10), 747-755.
20. Korvatska, E., Van de Water, J., Anders, T. F., Gershwin, M. E. (2002). Genetic and immunologic considerations in autism. Neurobiology of Disease, 9(2), 107-125.
21. Krug, D. A., Arick, J., & Almond, P. (1980). Behavior checklist for identifying severely handicapped individuals with high levels of autistic behavior. Journal of Child Psychology and Psychiatry, 21(3), 221-229.
22. Krug, D. A., Arick, J., & Almond, P. (1993). Autism screening instrument for educational planning. Examiner's manual (1st ed.). Austin, Texas: Pro-ed.
23. Kuddo, T., Nelson, K. B. (2003). How common are gastrointestinal disorders in children with autism?. Current Opinion in Pediatrics, 15(3), 339-343.
24. Lichtiger, S., Present, D. H., Kornbluth, A., Gelernt, I., Bauer, J., & Galler, G., et al. (1994). Cyclosporine in severe ulcerative colitis refractory to steroid therapy. New England Journal of Medicine, 330(26), 1841-1845.
25. Melamed, I., Griffiths, A. M., & Roifman, C. M. (1991). Benefit of oral immune globulin therapy in patients with immunodeficiency and chronic diarrhea. Journal of Pediatrics, 119(3), 486-489.
26. Melmed, R. D., Schneider, C. K., Fabes, R. A., Phillips, J., & Reichelt, K. (2000). Metabolic markers and gastrointestinal symptoms in children with autism and related disorders. Journal of Pediatric Gastroenterology and Nutrition, 31(Suppl 2), A116.
27. Messahel, S., Pheasant, A. E., Pall, H., Ahmed-Choudhury, J., Sungum-Paliwal, R. S., & Vostanis, P. (1998). Urinary levels of neopterin and biopterin in autism. Neuroscience Letters, 241(1), 17-20.
28. Molloy, C. A., & Manning-Courtney, P. (2003). Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism, 7(2), 165-171.
29. Money, J., Bobrow, N. A., & Clarke, F. C. (1971). Autism and autoimmune disease: a family study. Journal of Autism and Childhood Schizophrenia, 1(2), 146-160.
30. Myren, J., Bouchier, I. A., Watkinson, G., Softley, A., Clamp, S. E., & de Dombal, F. T. (1984). The O.M.G.E. Multinational Inflammatory Bowel Disease Survey 1976-1982. A further report on 2,657 cases. Scandinavian Journal of Gastroenterology. Supplement, 95, 1-27.
31. NIMH, (1985). CGI (Clinical Global Impression) scale. Psychopharmacology Bulletin, 21, 839-840.
32. Piven, J. (1997). The biological basis of autism. Current Opinion in Neurobiology, 7(5), 708-712.
33. Roberts, W., Weaver, L., Brian, J., Bryson, S., Emelianova, S., & Griffiths, A. M., et al. (2001). Repeated doses of porcine secretin in the treatment of autism: A randomized, placebo-controlled trial. Pediatrics, 107(5), E71.
34. Schott, J. M., Harkness, K., Barnes, J., della Rocchetta, A. I., Vincent, A., & Rossor, M. N. (2003). Amnesia, cerebral atrophy, and autoimmunity. Lancet, 361(9365), 1266.
35. Singh, V. K. (1996). Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. Journal of Neuroimmunology, 66(1-2), 143-145.
36. Singh, V. K., Warren, R., Averett, R., & Ghaziuddin, M. (1997). Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatric Neurology, 17(1), 88-90.
37. Sweeten, T. L., Bowyer, S. L., Posey, D. J., Halberstadt, G. M., & McDougle, C. J. (2003). Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics, 112(5), e420.
38. Sweeten, T. L., Posey, D. J., & McDougle, C. J. (2003). High blood monocyte counts and neopterin levels in children with autistic disorder. American Journal of Psychiatry, 160(9), 1691-1693.
39. Szatmari, P., Jones, M. B., Zwaigenbaum, L., MacLean, J. E. (1998). Genetics of autism: Overview and new directions. Journal of Autism and Developmental Disorders, 28(5), 351-368.
40. Takai, T. (2002). Roles of Fc receptors in autoimmunity. Nature Reviews Immunology, 2(8), 580-592.
41. Torrente, F., Anthony, A., Heuschkel, R. B., Thomson, M. A., Ashwood, P., & Murch, S. H. (2004). Focal-enhanced gastritis in regressive autism with features distinct from Crohn's and Helicobacter pylori gastritis. American Journal of Gastroenterology, 99(4), 598-605.
42. Torrente, F., Ashwood, P., Day, R., Machado, N., Furlano, R. I., & Anthony, A., et al. (2002). Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Molecular Psychiatry, 7(4), 375-382.
43. Torres, A.R., Maciulis, A., & Odell, D. (2001). The association of MHC genes with autism. Frontiers in Bioscience, 6, D936-D943.
44. Vincent, A., Lily, O., & Palace, J. (1999). Pathogenic autoantibodies to neuronal proteins in neurological disorders. Journal of Neuroimmunology, 100(1-2), 169-180.
45. Wakefield, A. J., Anthony, A., Murch, S. H., Thomson, M., & Montgomery, S. M., Davies, S., et al. (2000). Enterocolitis in children with developmental disorders. American Journal of Gastroenterology, 95(9), 2285-2295.
46. Warny, M., Fatimi, A., Bostwick, E. F., Laine, D. C., Lebel, F., & LaMont, J. T., et al. (1999). Bovine immunoglobulin concentrate-Clostridium difficile retains C. difficile toxin neutralising activity after passage through the human stomach and small intestine. Gut, 44(2), 212-217.